Panaxea supports informed decision making about healthcare innovation to improve health outcomes. In doing so, we add evidence to healthcare innovation by applying (early) health technology assessment, health services and policy research, and implementation science. We translate evidence into understandable, meaningful and actionable recommendations. We work together with our clients in defining the objectives and scope of work as well as the timelines and deliverables. In collecting and analyzing data we work systematically and objectively and follow international standards for research. We communicate with our clients from start to finish. We offer services to our clients for them to act upon the insights obtained. Our clients include health and life science innovators and investors, hospitals, health technology companies, governmental bodies, public and private payers, pharmaceutical companies, think tanks, and universities. Most of our clients are based in Europe, North America, and/or South-East Asia. Our team consists of experienced researchers and research consultants who understand the challenges of closing the innovation gap in healthcare. Our team is very experienced in translating findings from research to support decision making for better health outcomes.
| Website | http://www.panaxea.eu |
| Revenue | $1 million |
| Employees | 6 (0 on RocketReach) |
| Founded | 2010 |
| Phone | +31 20 740 0778 |
| Industry | Research Services, Software General, Software |
| Competitors | Roche, Novartis, Pfizer, Sanofi, GSK, AstraZeneca, Bristol Myers Squibb, Boehringer Ingelheim, Takeda, Ferring Pharmaceuticals +43 more (view full list) |
| SIC | SIC Code 87 Companies, SIC Code 873 Companies |
| NAICS | NAICS Code 5417 Companies, NAICS Code 54 Companies, NAICS Code 541 Companies |
Looking for a particular PANAXEA employee's phone or email?
The PANAXEA annual revenue was $1 million in 2026.
The NAICS codes for PANAXEA are [5417, 54, 541].
The SIC codes for PANAXEA are [87, 873].